Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus—the glass is half full!

摘要

Biomarkers for prognostication need large randomised controlled trials such as AspECT and BOSS. These trials will deliver surrogates which fulfil the validation criteria necessary for their introduction into the clinic